Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Endothelial Dysfunction and Risk of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation: END-GAME Prospective Study Final Results

Antonio Bianchessi, Irene Defrancesco, Virginia Valeria Ferretti, Cristina Picone, Beatrice Ferrari, Caterina Zerbi, Francesco Romano, Giulia Losi, Erica Consensi, Mara De Amici, Giorgia Testa, Valentina Zoboli, Alessia Taurino, Anna Amelia Colombo, Luca Arcaini, Nicola Polverelli

Blood (2024) 144 (Supplement 1): 3520.

https://doi.org/10.1182/blood-2024-208075

Published: 2024

Journal Articles

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Mara De Amici, Carlotta Abbà, MSc, Gianluca Viarengo, Laura Villani, Margherita Massa, Vittorio Rosti, MD

Blood (2019) 134 (Supplement_1): 1678.

https://doi.org/10.1182/blood-2019-125531

Published: 2019

Journal Articles

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Margherita Massa, Rita Campanelli, Gabriela Fois, Laura Villani, Elisa Bonetti, Paolo Catarsi, Valentina Poletto, Gianluca Viarengo, Mara De Amici, Vittorio Rosti, Robert Peter Gale, Giovanni Barosi

Blood (2016) 128 (12): 1660–1662.

https://doi.org/10.1182/blood-2016-03-704577

Published: 2016

Includes: Supplemental data

Journal Articles

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

Rita Campanelli, BS, Gabriela Fois, BS, Carlotta Abbà, BS, Mara De Amici, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Giovanni Barosi, MD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2015) 126 (23): 1639.

https://doi.org/10.1182/blood.V126.23.1639.1639

Published: 2015

Journal Articles

The Administration of Fondaparinux in Strongly Suspected Heparin-Induced Thrombocytopenia (HIT): Further Evidence of Its Safety and Efficacy, and Need for a Controlled Randomized Study.

Franco Piovella, MD, Stefano Barco, Marisa Barone, Chiara Beltrametti, Mara De Amici

Blood (2009) 114 (22): 1072.

https://doi.org/10.1182/blood.V114.22.1072.1072

Published: 2009

Journal Articles

Efficacy of Fondaparinux in the Treatment of Heparin-Induced Thrombocytopenia with Venous Thromboembolism: Reduction of Thromboembolic Burden, Normalization of Platelet Count and Disappearance of Anti-Platelet Factor 4/Heparin Antibodies.

Franco Piovella, MD, Marisa Barone, MD, Chiara Beltrametti, MD, Chiara Piovella, MD, Andrea M. D’Armini, MD, Federico Capra Marzani, MD, Vittorio Arici, MD, Mara De Amici, MD, Stefano L. Barco, MS, Gianluca Castellani, MD, Martin Langer, MD

Blood (2006) 108 (11): 575.

https://doi.org/10.1182/blood.V108.11.575.575

Published: 2006

Journal Articles

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Patrizia Zappasodi, MD, Alessandro Corso, MD, Chiara Rusconi, MD, Mara De Amici, Erica Consensi, Cristiana Pascutto, Marzia Varettoni, MD, Silvia Mangiacavalli, MD, Gianmatteo Pica, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 5068.

https://doi.org/10.1182/blood.V106.11.5068.5068

Published: 2005

NARROW

Endothelial Dysfunction and Risk of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation: END-GAME Prospective Study Final Results

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

The Administration of Fondaparinux in Strongly Suspected Heparin-Induced Thrombocytopenia (HIT): Further Evidence of Its Safety and Efficacy, and Need for a Controlled Randomized Study.

Efficacy of Fondaparinux in the Treatment of Heparin-Induced Thrombocytopenia with Venous Thromboembolism: Reduction of Thromboembolic Burden, Normalization of Platelet Count and Disappearance of Anti-Platelet Factor 4/Heparin Antibodies.

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Email alerts

ASH Publications

American Society of Hematology

Endothelial Dysfunction and Risk of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation: END-GAME Prospective Study Final Results

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Reduced frequency of circulating CD4 + CD25 bright CD127 low FOXP3 + regulatory T cells in primary myelofibrosis

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

The Administration of Fondaparinux in Strongly Suspected Heparin-Induced Thrombocytopenia (HIT): Further Evidence of Its Safety and Efficacy, and Need for a Controlled Randomized Study.

Efficacy of Fondaparinux in the Treatment of Heparin-Induced Thrombocytopenia with Venous Thromboembolism: Reduction of Thromboembolic Burden, Normalization of Platelet Count and Disappearance of Anti-Platelet Factor 4/Heparin Antibodies.

Modification of Cytokine Levels and CD34+ Stem Cell Adhesion Molecules during Mobilization in Multiple Myeloma (MM) Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only